Your browser doesn't support javascript.
loading
Randomized, 6-Week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit/Hyperactivity Disorder: Individualized Dosing of Osmotic-Release Oral System (OROS) Methylphenidate With a Goal of Symptom Remission.
Goodman, David W; Starr, H Lynn; Ma, Yi-Wen; Rostain, Anthony L; Ascher, Steve; Armstrong, Robert B.
Afiliação
  • Goodman DW; Suburban Psychiatric Associates, LLC; Adult Attention Deficit Disorder Center of Maryland; and Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Starr HL; Director, Medical Affairs, Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Rd, Titusville, NJ 08560. HStarr@its.JNJ.com.
  • Ma YW; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
  • Rostain AL; Johnson & Johnson Consumer Inc, Horsham, Pennsylvania, USA.
  • Ascher S; University of Pennsylvania Adult ADHD Treatment and Research Program, Department of Psychiatry, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • Armstrong RB; Janssen Pharmaceutical Development, LLC, Titusville, New Jersey, USA.
J Clin Psychiatry ; 78(1): 105-114, 2017 01.
Article em En | MEDLINE | ID: mdl-27487193

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Medicina de Precisão / Metilfenidato Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Medicina de Precisão / Metilfenidato Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article